OUR CEO
Michael West, PhD
Experienced researcher
-
Visiting Fellow NCI NIH – Discovered key variants of histone H2A (H2A.X, H2A.Z)
-
Visiting Associate NIADDK – Developed first AAV vector
Industry Experience
-
Allelix – Staff Scientist running protein sequencing service
-
IPT – Founder and CSO – recruited one scientist and two technicians
-
Service company – Protein sequencing and peptide synthesis
Micrologix Biotech (public company) Drug Development
-
CSO – hiring key personnel, building R&D team, foundation of company’s R&D activities, managing preclinical and regulatory activities, presenting company program to FDA
GlycoDesign (private and public) Drug Development
-
VP- Preclinical – realigning R&D program, re-investigating company technology, advising on clinical program
Proteocyte AI
-
Advisor – preparing presentations and explaining value proposition to senior management Government Experience
NRC-IRAP
-
Managing client portfolio, assigning priorities, identifying client needs, assisting in preparing proposals and recommendations for funding, Assessing proposals for business and technical potential and recommending funding.
